A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL).

Michael Frank, CEO of Revive, commented: “We look forward to collaborating with a top U.S. cancer istitute to investigate Bucillamine’s potential for solid tumors, confirming its anti-inflammatory and ...

Investigators conducted a 4T1 breast cancer mouse model study to assess whether a combination of Shenhuang plaster, an herbal formula, plus paclitaxel could enhance the anti-tumor effects of ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more effectively.

Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives ...

Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, ...

Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part ...

Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds ...